Board of Directors
CFO, Founder and Board Member
Dr. David Brown
Dr. V Paul Gerskowitch
Dr. Ian Fotheringham
Ian Fotheringham is the CEO at Ingenza Ltd and has been hugely supportive of the company since the business relationship started. He represents Ingenza’s interest in PFP as well as providing technical advice. He received a Ph.D. in Molecular Biology with Professor David Sherratt at the University of Glasgow in 1986. Joining the NutraSweet division of Monsanto Corporation in Chicago IL, he then spent 6 years developing microbial strains for the manufacture of L-phenylalanine and the peptide sweetener Aspartame.
Eugenia brings 30 years of experience in Commercial Operations and General Management in the Pharma/Biotech world. She has worked for several top pharmaceutical companies (GSK, Boehringer Ingelheim and Sanofi), driving the launch and commercialization of several global brands. She has worked as VP Commercial Operations for Emerging markets at Sanofi, working closely with local teams across the region to optimize the commercial performance and was General Manager for Sanofi UK (General Medicines). In 2020, she moved to Healx, where she worked as VP Commercial and Operations, developing the commercial portfolio strategy and setting up program management, before joining PFP in July 2023.
Professor John H McVey PhD, FRCPath
Founder & Chief Scientist
Director of Regulatory Affairs and QA, Founder